Adam Vogel
Stock Analyst at Craig-Hallum
(2.95)
# 2,550
Out of 4,396 analysts
26
Total ratings
57.1%
Success rate
6.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics | Initiated Coverage: Buy | $43 | $29.27 | +46.91% | 1 | May 21, 2026 | |
| DSGN Design Therapeutics | Rated: Buy | $15 → $22 | $10.55 | +108.53% | 4 | May 19, 2026 | |
| IMNM Immunome | Maintained: Buy | $36 | $18.39 | +95.76% | 7 | May 13, 2026 | |
| LBRX LB Pharmaceuticals | Maintained: Buy | $36 | $29.36 | +22.62% | 3 | May 13, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $4.30 | +132.56% | 5 | May 7, 2026 | |
| HIT Health In Tech | Maintained: Buy | n/a | $1.05 | - | 1 | Apr 10, 2026 | |
| APGE Apogee Therapeutics | Maintained: Buy | $116 → $114 | $85.02 | +34.09% | 5 | Mar 24, 2026 |
MapLight Therapeutics
May 21, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $29.27
Upside: +46.91%
Design Therapeutics
May 19, 2026
Rated: Buy
Price Target: $15 → $22
Current: $10.55
Upside: +108.53%
Immunome
May 13, 2026
Maintained: Buy
Price Target: $36
Current: $18.39
Upside: +95.76%
LB Pharmaceuticals
May 13, 2026
Maintained: Buy
Price Target: $36
Current: $29.36
Upside: +22.62%
Aclaris Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $4.30
Upside: +132.56%
Health In Tech
Apr 10, 2026
Maintained: Buy
Price Target: n/a
Current: $1.05
Upside: -
Apogee Therapeutics
Mar 24, 2026
Maintained: Buy
Price Target: $116 → $114
Current: $85.02
Upside: +34.09%